Market Tracker

08/17 5:16pm ET

Protalix Biotherapeutics Inc (NYSE American:PLX)

0.5442
Delayed Data
As of 3:59pm ET
 -0.0156 / -2.79%
Today’s Change
0.26
Today|||52-Week Range
1.51
+22.29%
Year-to-Date
No recent news for Protalix Biotherapeutics Inc.

Today’s Trading

Previous close0.56
Today’s open0.56
Day’s range0.54 - 0.58
Volume454,878
Average volume (3 months)1,187,640
Market cap$74.7M
Dividend yield--
Data as of 3:59pm ET, 08/17/2017

Growth & Valuation

Earnings growth (last year)-251.54%
Earnings growth (this year)-77.59%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+110.79%
P/E ratioNM
Price/Sales4.90
Price/Book--

Competitors

 Today’s
change
Today’s
% change
MTFBMotif Bio PLC-0.02-0.29%
ADMAADMA Biologics Inc+0.02+0.66%
SRRASierra Oncology Inc-0.02-1.64%
AQBAquaBounty Technolog...-0.03-0.41%
Data as of 3:59pm ET, 08/17/2017

Financials

Last reporting dateAugust 9, 2017
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$9.2M
Annual profit (last year)-$29.4M
Net profit margin-317.16%

Profile

Sector
Health Services
Industry
Services to the Health Industry
President, Chief Executive Officer &
Director
Moshe Manor
Chief Operating Officer
Tzvi Palash
Corporate headquarters
Carmiel, Hazafon

Forecasts